Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

  • HOME
  • BROWSE ARTICLES
  • Previous issues
18
results for

Previous issues

Article category

Keywords

Previous issues

Prev issue Next issue

Volume 6(2); June 2000

Original Articles

The Change of Transforming Growth Factor-β1 Expression and the Effect of Vitamin E in the Acute Rat Liver Injury with Carbon Tetrachloride
Jung Il Lee, Kwan Sik Lee, Jun Pyo Chung, Young Nyun Park1 , Se Joon Lee, Kwang Hyub Han, Chae Yoon Chon, Sang In Lee, Young Myoung Moon, Hyon-Suk Kim2
Korean J Hepatol 2000;6(2):147-155.
Background/Aims
The evaluation of the relationship between oxidative stress induced by acute carbon tetrachloride (CCl4) administration and transforming growth factor-β1 (TGF-β1), and the investigation of temporal patterns of serum alanine aminotransferase (ALT) and TGF-β1 expression which may clarify the pathogenesis of CCl4 induced liver injury and thus the mechanism of liver fibrogenesis. The aim of this study was to investigate TGF-β1 expression in rats with acute CCl4 injury and effect of vitamin E (vit. E) on TGF-β1 expression. Methods: Sixty male Sprague-Dawley rats had a single intraperitoneal injection of CCl4, of which 30 rats had daily intraperitoneal injection of vit. E, starting from 2 days before CCl4 treatment until the time of their sacrifice. The group of rats with CCl4 injection only was designated as group 1 and the group of rats with vit. E combined treatment was designated as group 2. Five rats from each group were sacrificed before and 8, 16, 32, 48, 60 hours after CCl4 injection, and their serum ALT, serum TGF-β1, and hepatic expression of TGF-β1 were examined. Results: The serum ALT levels were highest at 32 hours after CCl4 injection in both groups, serum TGF-β1 levels did not show any statistically significant changes after CCl4 injection in both groups, and TGF-β1 expression in the livers was highest at 32 hours after CCl4 injection in both groups. In the multiple regression analysis of vit. E's effect on serum ALT levels, serum TGF-β1 levels and hepatic TGF-β1 expression, only serum ALT level (p=0.049) and hepatic TGF-β1 expression (p=0.015) showed statistically significant suppression. Conclusion: Oxidative stress seems to play a role in the pathogenesis of hepatic fibrogenesis by increasing TGF-β1 expression in early acute liver damage. and vit. E may be effective in reducing acute liver injury and hepatic fibrogenesis. (Korean J Hepatol 2000;6:147-155)
  • 3,032 View
  • 16 Download
Quantitation of Hepatitis C Virus RNA by Competitive RT-PCR and DNA-ELISA Method
Kang Seok Seo, M.D., Seung Jung Kee1, M.D., Soon Pal Suh1, M.D., Sei Jong Kim, M.D.
Korean J Hepatol 2000;6(2):156-171.
Background/Aims
Quantitation of Hepatitis C Virus (HCV) RNA in serum is important for monitoring the response to interferon-α therapy in patients with chronic hepatitis C. Several commercial assays are recently available, but they are expensive and cannot be used as a gold standard. Methods: An in-house competitive reverse transcription-polymerase chain reaction (cRT-PCR) was developed and validated. The procedure involves the construction of a mutant and wild type HCV RNA internal standard (IS), cRT-PCR, and colorimetric detection with DNA-ELISA. A standard curve was obtained and used for final HCV RNA quantitation. Results: The standard curve was linear over the range of 1×104 to 5×107 copies/mL of the HCV RNA standard (r=0.976). This in-house cRT-PCR was comparable with the branched DNA (bDNA) assay (Quantiplex HCV 2.0, Chiron, USA) with positive correlation between the two tests (r=0.735). Conclusion: The quantitation of HCV RNA by in-house cRT-PCR and DNA ELISA was more sensitive and had wider range of detection compared to bDNA assay. This assay is useful for follow-up of HCV RNA concentration after interferon-α therapy.(Korean J Hepatol 2000;6:156-171)
  • 3,430 View
  • 29 Download
The Effect of Lamivudine in Chronic Liver Disease associated with Hepatitis B Virus
Kwang Hee Kim, M.D., Soon Ho Um, M.D., Ho Sang Ryu, Jae Won Lee* , Young Sun Kim, M.D., Yoon hong Kim, M.D., Jung Whan Lee, M.D., Chang Don Kang, M.D., Byung Won Hur, Yoon Tae Jin, Hoon Jai Chun, Chi Wook Song, M.D., Sang Woo Lee, M.D., Jai Hyun Choi, M.D., Chang Duck Kim, M.D., Jin Hai Hyun, M.D.
Korean J Hepatol 2000;6(2):172-186.
Background/Aims
Lamivudine has demonstrated a potent suppression of viral replication and a substantial histologic improvement in many patients with chronic hepatitis B. This study is intended to evaluate the effects of lamivudine and the breakthrough rate in patients with HBV associated chronic liver diseases including decompensated liver cirrhosis, and to investigate the clinical factors closely related with these events. Methods: A total of 58 patients(chronic hepatitis 21, cirrhosis 37) showing abnormal serum levels of aminotransferase and detectable serum HBV DNA for at least 6 month received 150 mg of lamivudine once a day for 3-27 months (median 13). The Kaplan-Meier methods and the Cox regression model were used for statistic analysis. Results: The one-year cumulative incidences of the negative conversion of serum HBV DNA, normalization of aminotransferase, and seroconversion of HBeAg were 98.3%, 86.2% and 20.6%, respectively. Eighteen-month and 2-year cumulative breakthrough rates were 24% and 47%, respectively. The Child-Pugh scores were improved (p<0.001) in patients with decompensated liver cirrhoses(n=21). The negative conversion of HBV DNA, breakthrough rates and seroconversion were not significantly associated with the progression of disease, mutation in pre-core region and previous treatment with interferon. The pre-treatment aspartate aminotransferase (AST) level was associated with a higher rate of seroconversion(p<0.03). Conclusion: Despite a higher breakthrough rate, 2-year lamivudine treatment has induced the seroconversion of HBeAg in 26% of patients, and improved the clinical manifestations in decompensated cirrhotic patients.(Korean J Hepatol 2000;6:172-186)
  • 3,458 View
  • 28 Download
Clinical and Pathological Manifestations of Idiopathic Portal Hypertension
Jun Hong Lee, M.D., Dae Hwan Kang, M.D., Chang Hun Lee, M.D.*, Geun Am Song, M.D., Mong Cho, M.D., Ung Suk Yang, M.D.
Korean J Hepatol 2000;6(2):187-196.
Backgroud/Aims: Idiopathic portal hypertension (IPH) is defined as portal hypertension with splenomegaly and hypersplenism in the absence of cirrhosis or obstruction of portal vein or hepatic vein. It has been recently suggested that hypercoagulable state and thromboembolic event of small portal veins have an important role in the pathogenesis of IPH. In this study, we evaluated the clinical and pathological characteristics of IPH. Methods: We reviewed clinical, endoscopic, radiologic and liver biopsy findings of 10 cases of IPH retrospectively. Results: The tests for antithrombin III deficiency, protein C deficiency, protein S deficiency, resistance to activated protein C, lupus anticoagulant, antiphospholipid antibodies, anticardiolipin antibodies were normal. Pathologic findings revealed portal vein dilatation (10/10), loss of portal vein (6/10), portal vein sclerosis (1/10), dilated megasinusoids (9/10), dilation of terminal hepatic vein (8/10), narrowing of terminal hepatic vein (2/10), hairline fibrous septa (1/10), and regenerative nodule (1/10). Conclusions: The pathologic finding of IPH showed various manifestations of obliterative portal venopathy although there was no hypercoagulable state.(Korean J Hepatol 2000;6:187-196)
  • 3,391 View
  • 15 Download
A Study for Hypoxemic Mechanisms in Liver Cirrhosis
Jung Woo Shin, M.D., Il Han Song, M.D., Myoung Ju Ki, M.D., Moo Yong Rhee, M.D., and Seok Gun Park, M.D.1
Korean J Hepatol 2000;6(2):197-204.
Background/Aims
Hypoxemia is often associated with liver cirrhosis without cardiopulmonary diseases. Pulmonary vascular impairments including intrapulmonary shunt have been considered as a major mechanism of hypoxemia. The aim of this study was to determine the incidence and pathophysiologic basis of hypoxemia in cirrhotic patients without respiratory symptoms. Methods: In fourty three cirrhotic patients without heart and lung diseases, we performed the arterial blood gas analysis and calculated alveolar arterial oxygen gradient (A-aO2). According to the A-aO2, the patients were divided into hypoxemic and normoxemic groups. In each group, a Tc-99m-macroaggregated albumin (Tc-99m-MAA) scan, a contrast-enhanced echocardiography and a pulmonary function test were performed. Results: Twenty-eight of 43 patients (65%) showed hypoxemia. Hypoxemic patients showed significantly more increased shunt fraction of 3.1 1.4% than normoxemic one of 2.1 1.1% in the Tc-99m-MAA scan (p<0.05). However, only two of hypoxemic patients had shunt fraction above physiologic shunt range. By contrast-enhanced echocardiography, an intrapulmonary shunt was confirmed in one patient. There was no significant correlation between the shunt fraction and the hepatic reserve based on the Child-Pugh classification in hypoxemic patients. In the results of pulmonary function test, only DLco decreased more significantly in hypoxemic group than in normoxemic group (58.4 14.2 % vs 75.3 16.5% of predicted, p<0.05). Conclusions: Hypoxemia is not infrequently observed in cirrhosis, but incidence of significant intrapulmonary shunt is low. Therefore, other mechanism such as diffusion defect may be suggested to play a role in the development of hypoxemia in cirrhotic patients without respiratory symptoms. (Korean J Hepatol 2000;6:197-204)
  • 3,360 View
  • 19 Download
Clinical Usefulness of PIVKA-II and Lens Culinaris Agglutinin-A Reactive Alpha-fetoprotein(AFP-L3) for the Diagnosis of Hepatocellular Carcinoma
B.H. Byun, Y.M. Park, S.H. Bae, J.Y. Choi, K.Y. Sung, S.H. Cho, N.I. Hahn, J.M. Yang, S.O. Choi, S.B. Cha, K.W. Chung, H.S. Sun, D.H. Park, B.S. Kim
Korean J Hepatol 2000;6(2):205-214.
Background/Aims
Des-γ-carboxy prothrombin(DCP), a protein induced by vitamin K absence or antagonist-II(PIVKA-II), and Lens culinaris agglutinin-A reactive AFP-L3 have been reported to be useful markers for the diagnosis of hepatocellular carcinoma (HCC). In the present study, both the PIVKA-II and AFP-L3 were analyzed and compared with a conventional AFP to determine its usefulness, specificity and sensitivity in the diagnosis of HCC. Methods: Sera were collected from 108 patients consisting of 17 patients with chronic hepatitis, 22 patients with liver cirrhosis and 69 patients with HCC. The AFP-L3 was determined by an lectin affinity electrophoresis coupled with an antibody-affinity blotting. Level of DCP was measured by an enzyme immunoassay with an anti-DCP monoclonal antibody. Results: The sensitivity and specificity of PIVKA-II and AFP L3 were 49.3% and 89.5%, and 32.5% and 85.7%, respectively. No significant correlation was found between the PIVKA-II or AFP L3 and serum AFP. No correlation was found between the PIVKA-II or AFP L3 and the characteristics of HCC. Conclusion: The determination of plasma DCP and AFP L3 levels combined with AFP levels may be useful especially for the differential diagnosis between HCC and chronic liver diseases without HCC.(Korean J Hepatol 2000;6:205-214)
  • 3,772 View
  • 38 Download
Thrombocytopenia between Decompensated Alcoholic and Viral Liver Cirrhosis
Eun Sil Koo, M.D., Byung Ik Kim, M.D., Si Young Kim, M.D., Yong Kyun Cho, M.D. Chang Sub Kim, M.D., Chang Young Park, M.D., Chong Il Sohn, M.D., Woo Kyu Jeon, M.D. Eul Soon Jung, M.D. Dong Kug Kum, M.D.*, Young Rae Lee, M.D.† Hwa Young Lee, M.D.‡ , Sang Jong Lee, M.D.‡
Korean J Hepatol 2000;6(2):215-222.
Background/Aims
Thrombocytopenia is frequently found among patients with chronic liver disease, and its mechanism, especially among patients with decompensated liver cirrhosis had not been established. Therefore to elucidate the mechanism of thrombocytopenia, the relationship between thrombocytopenia and severity of hepatic dysfunction, splenomegaly was measured. We measured the peripheral blood components with splenic volume obtained from a computerized tomography of decompensated liver cirrhosis patients. Methods: We studied 103 patients who had been diagnosed with decompensated liver cirrhosis with esophageal varices and ascites from January 1982 to August 1999. We checked their counts of platelets, albumin, bilirubin, splenic volume, degree of esophageal varices, hepatic encephalopathy and ascites by retrograde methods. Results: In viral liver cirrhosis, thrombocytopenia and splenomegaly correlated well with disease severity but they didn't in alcoholic cirrhosis. Of special note, the platelet count was significantly lower and the splenic volume was larger in the Child C of viral cirrhosis patients group than in the alcoholic group(p<0.05). Conclusion: When we compared decompensated alcoholic with viral liver cirrhosis patients, the degrees of thrombocytopenia and splenomegaly were much less in the former group. The factors for this phenomena are Splenic Pooling theory, Platelet-associated IgG, Thrombopoietin and Toxic Marrow. We suggest that splenomegaly is an important factor among these, but the mechanisms involved in the pathogenesis of this hematologic phenomena are not completely understood. Especially in alcoholic liver cirrhosis, many other factors may be involved, including the direct effect of alcohol to bone marrow, so further studies will be needed to establish whether a causal relationship exists.(Korean J Hepatol 2000;6:215-222)
  • 3,637 View
  • 29 Download

Case Reports

Primary Biliary Cirrhosis Associated with Multiple Renal Abscess and IgA Nephropathy : A Case Report
Jung Woo Shin,Il Han Song,Myoung Ju Ki,Chang Young Lim,Jong Tae Cho
Korean J Hepatol 2000;6(2):223-228.
Primary biliary cirrhosis is a chronic progressive disease most often affecting women. It is characterized by the progressive destruction of the small intrahepatic bile ducts with portal inflammation leading to hepatic fibrosis and cirrhosis. Autoimmune diseases such as Sjogren's syndrome, rheumatoid arthritis, dermatomyositis, CREST syndrome, and autoimmune thyroiditis may be found in up to 80% of the patients. Primary biliary cirrhosis is also associated with renal diseases such as distal renal tubular acidosis, bacteriuria and glomerulopathy, but there is no case report of primary biliary cirhosis with renal manifestations in Korea. We are reporting a case of primary biliary cirrhosis with multiple renal abscess and IgA nephropathy with a review of the literature.(Korean J Hepatol 2000;6:223-228)
  • 3,394 View
  • 17 Download
A Case of Hypereosinophilic Syndrome with Hepatic and Gastrointestinal Involvement
Duc ky Rhee,Hyun Min Shin,Doo Yul Ryu,Jong Hyung Kim,Dong In Hawng,Dong Joo Lee,Seok Eun Kim,Suk Joon Park
Korean J Hepatol 2000;6(2):229-235.
Hypereosinophilic syndrome is characterized by prolonged eosinophilia of blood and tissue without an identifiable underlying cause and multiorgan system dysfunction by eosinophil-related tissue damage to variable organs: liver, heart, lung, kidney, gastrointestinal tract, skin, nerve. Some case of hypereosinophilic syndrome with hepatic and gastrointestinal involvement have been reported, but not much. We are reporting a case of hypereosinophilic syndrome with hepatic and gastrointestinal involvement in 56-year-old man who presented general weakness and epigastric discomfort. In abdominal US, CT and MRI, intrahepatic multifocal ill-defined lesions were detected. The patient was treated with prednisolone for 16 weeks and recovered from eosinophilia and gastric involvement. A gastric biopsy was taken to confirm recovery. Also, the ill-defined lesions in US and CT disappeared after treatment.(Korean J Hepatol 2000;6:229-235)
  • 3,341 View
  • 18 Download
Fluoxetine-induced Acute Toxic Hepatitis
Seong Jae Kwak, M.D., Heung Young Oh, M.D., Mi Ae Yeo, M.D., Soo Hyun Park, M.D., Jee Soo Kim, M.D., Joon Sang Lee, M.D., Joong Seo Lee, M.D.1, and Hyung Gun Kim, M.D.
Korean J Hepatol 2000;6(2):236-240.
Fluoxetine (Prozac(R) ) is a antidepressant that inhibits the reuptake of serotonin in central nervous system, and has lesser adverse effects than the tricyclic antidepressants. The adverse effects of this drug are various, and the most common side effects are headache and nausea. The hepatic injury caused by fluoxetine is reported but very rare and not well known. Literature review has shown only 3 cases of hepatotoxicity from fluoxetine. We regard our case as the first of the hepatotoxicity from fluoxetine in Korea. The patient that we experienced showed normal aspartate aminotransferase (AST) and alanine aminotransferase (ALT) values before fluoxetine administration. 15 days after she took fluoxetine, AST and ALT values were increased and gradually increased as she took fluoxetine daily. We studied about viral hepatitis, metabolic liver disease, and autoimmune liver disease, but the cause of hepatic injury was not established. After the patient stopped to take fluoxetine, AST and ALT values decreased. A liver biopsy showed a moderate infiltration within the portal tracts with lymphocytes and ballooning degeneration of hepatocytes. We concluded fluoxetine-induced acute toxic hepatitis had occured. We must keep in mind that fluoxetine may cause hepatitis without cholestasis and suggest taking liver function tests regularly.(Korean J Hepatol 2000;6:236-240)
  • 5,851 View
  • 60 Download
Hepatic Septal Fibrosis Induced by Long-term Use of Ketoconazole
Jae Wan Cho, M.D., Yoon Ho Ko, M.D., Yong Kyun Kim, M.D., Young Chul Kim, M.D., Yong Jick Sung, M.D., Si Hyun Bae, M.D., Jin Il Kim, M.D., Choon Sang Bang, M.D., Byung Min Ahn, M.D., Young Min Park, M.D., Kyu Won Chung, M.D., Hee Sik Sun, M.D., Doo Ho Park, M.D., Boo Sung Kim, M.D. and Seok Jin Kang, M.D.*
Korean J Hepatol 2000;6(2):241-245.
Ketoconazole, an imidazole derivative, is a broad spectrum antifungal agent which has been used widely in the treatment of systemic or local fungal infections. Mild asymptomatic elevation of plasma transaminase activities occurs in approximately 6% to 17.5% of patients who have used ketoconazole. However, the incidence of symptomatic hepatic injury is low and overt hepatitis develops in about 5% of the patients. Nausea and vomiting are the most frequent side reactions. Histopathological features of the reported ketoconazole induced hepatotoxicity are massive or submassive hepatocellular necrosis involving the acinar zone 3, destroyed lobular architecture with bridging necrosis and inflammatory cell infiltration on portal tracts. However, hepatic septal fibrosis with liver cirrhosis has not been reported yet.We experienced a case of hepatic septal fibrosis that developed after 9 months of ketoconazole administration.(Korean J Hepatol 2000;6:241-245)
  • 3,228 View
  • 17 Download

Cyber Hepatology

Liver Transplantation and Internet
Joon Yeol Han
Korean J Hepatol 2000;6(2):246-248.
  • 3,185 View
  • 15 Download

Hepatology Elsewheres

원발성 간암은 간경변이 동반되는 경우가 대부분이기 때문에 그 예후는 암 자체의 진행 정도뿐만 아니라 잔여 간기능과도 관련이 있다. The Cancer of the Liver Italian Program(CLIP) score는 종양 인자 외에 Child- Pugh 등급, α- FP 치, 간문맥 혈전을 인자로 포함하는 새로운 병기 분류법으로 이미 보고된 바 있다(표 1).1 본 연구에서는 이 분류법의 간암 예후 결정력에 대하여 전향적으로 분석하여 기존의 Okuda 분류법2 (표 2) 과 비교하였다. 결과는 간암의 예후를 반영하는데 있어서 두 분류법은 상관관계가 좋았으나, 다변량 분석에서 CLIP score가 좀 더 우수한 결과 를 보였다.
  • 3,634 View
  • 17 Download
최근 영상 진단술의 발달에 힘입어 소 간세포결절(small hepatocellular nodule)의 발견이 매우 용이해졌으며, 여러 가지 영상 진단법 중에서도 특히 Computed Tomography During Arterial Portography (CTAP)는 종양 내 혈행동태의 변화를 가장 민감하게 반영하므로 간세포암의 진단 시 유용하게 사용된다. 그러나 일부의 고분화성 간세포암은 혈행동태가 양성 간세포 결절과 유사하거나 매우 제한적인 변화만을 보여 CTAP에 의해 검출되지 않는 경우도 있는 것으로 알려져 있다. 본 연구는 21명의 만성 간질환 환자에서 초음파 검사로는 병변이 검출되었으나 CTAP로는 검출이 불가능하였던 31개 소결절을 대상으로 영상 및 병리학적 분석을 통하여 고분화성 간세포암과 양성 간세포 결절을 감별 할 수 있는 특징적 영상소견을 알아보고자 하였다. 조직진단 결과, 31개 결절 중 17개(55%)가 간세포암이었으며, 1개는 고도 이형성 결절, 13개는 양성 결절이었다. 이들 병변에 대한 단순 컴퓨터 단층촬영법(plain CT )의 검출율은 간세포암의 경우 17예 중 5예(29%), 고도 이형성 결절의 경우 1예 중 1예(100%), 양성 결절의 경우 13예 중 1예(8%)였으며, T 1·T2강조 자기공명영상법(MRI)의 검출율은 간세포암의 경우 17예 중 4예(24%), 고도이형성 결절의 경우 1예 중 1예(100%), 양성 결절의 경우 13예 중 3예(23%)였다. 한편, 이들 결절은 디지털 감쇄 혈관조영술(DSA)로는 발견할 수 없었으며, CT arteriography, 조영증강 CT , 조영증강 MRI는 단순 CT나 단순 MRI에 비해 더 나은 정보를 제공해주지 못하였다. 결론적으로, 만성 간질환 환자에서는 초음파검사 상 명백한 병변으로 검출되나 CTAP로는 가시화되지 않는 간세포성 소결절이 존재하며, 이들 중 반 수는 간세포암일 가능성이 있으나 현재 사용되는 영상 진단술만으로 이들 병변의 양,악성을 가리기는 어려우므로 조직생검이 필요하다.
  • 3,245 View
  • 17 Download

Liver Pathology

Sclerosing Hepatic Carcinoma
Young Nyun Park,Chanil Park
Korean J Hepatol 2000;6(2):252-254.
  • 3,258 View
  • 15 Download

Liver Imaging

Pyogenic Liver Abscess
Joon Koo Han
Korean J Hepatol 2000;6(2):255-256.
  • 3,227 View
  • 24 Download

EM Image in Hepatology

The Morphology of Liver through the Electron Microscope(8)
Tae Joong Sohn
Korean J Hepatol 2000;6(2):257-264.
  • 3,097 View
  • 15 Download

Others

Chelidonium majus var asiatica
Byung Min Ahn
Korean J Hepatol 2000;6(2):265-266.
  • 2,861 View
  • 14 Download